Clinical Trial

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Name: ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT06775860)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A randomized, double-blind, placebo-controlled phase III study evaluating the efficacy and safety of oral ICP-332 in subjects with moderate to severe atopic dermatitis

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-01-09.

Trial Details

NCT Number	NCT06775860
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Atopic Dermatitis
Enrollment	552 participants
Start Date	2024-11-14
Primary Completion	2026-11-25 (estimated)
Study Completion	2026-12-25 (estimated)
Updated on ClinicalTrials.gov	2025-09-08